[Pre-diabetes mellitus influenced by hyperuricemia].
Zhe Jiao1, Han-lu Gao, Hang Li
1Department of Epidemiology, School of Public Health, Harbin Medical University, Harbin 150081, China.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi
|November 22, 2013
Summary
High uric acid levels in pre-diabetes mellitus patients are linked to dyslipidemia and insulin resistance. Monitoring uric acid is crucial for preventing diabetes progression and managing metabolic health.
Area of Science:
- Endocrinology and Metabolism
- Clinical Biochemistry
Background:
- Pre-diabetes mellitus (PDM) is a metabolic state preceding type 2 diabetes.
- Hyperuricemia (HUA), characterized by elevated uric acid levels, is increasingly recognized as a potential risk factor in metabolic disorders.
Purpose of the Study:
- To investigate the relationship and influence between pre-diabetes mellitus and hyperuricemia.
- To explore the association of uric acid levels with key metabolic indicators in PDM patients.
Main Methods:
- A cohort of 157 pre-diabetes mellitus patients (aged 20-75) were divided into hyperuricemia (HUA) and normal uric acid (NUA) groups.
- Statistical analyses included T-tests and Pearson correlation to assess differences and relationships between uric acid and biochemical markers.
- Patients on thiazide drugs were excluded to ensure unbiased results.
Main Results:
- Patients with hyperuricemia exhibited significantly higher BMI, triglycerides (TG), total cholesterol (TC), LDL-C, and HOMA-IR compared to the normal uric acid group.
- Pre-diabetes uric acid levels showed positive correlations with TG, TC, and LDL-C.
- A negative correlation was observed between HOMA-IR and HbA1c.
Conclusions:
- Elevated uric acid levels in pre-diabetes are associated with dyslipidemia (elevated TC, TG, LDL-C) and insulin resistance (HOMA-IR).
- High uric acid levels, particularly when linked to HOMA-IR, may accelerate the progression from pre-diabetes to diabetes.
- These findings underscore the importance of monitoring uric acid levels in individuals with pre-diabetes.
More Related Videos
10:31An Experimental Model of Diet-Induced Metabolic Syndrome in Rabbit: Methodological Considerations, Development, and Assessment
Published on: April 20, 2018
10.3K
06:59Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test
Published on: November 13, 2016
10.5K
Related Concept Videos
01:29Hyperglycemia
34
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose...
34
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
32
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated...
32
01:28Diabetic Nephropathy
49
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...
49
01:22Diabetes Mellitus: Type 2 and Gestational
5.0K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.0K
01:19Type I Diabetes III: Clinical Manifestations
31
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the...
31
01:24Type II Diabetes II: Pathophysiology
36
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
36